UPC
Universe Pharmaceuticals INC
$6.32
+0.76 (+13.67%)
At close · Jul 2
Market Cap
$4.20M
Shares
563,338
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.32
Open$5.10
Day$4.81–6.43
52W$2.00–17.96
Avg vol 30d2.8M
Short int12K · 2.1% float · 1.0d
Short vol52%
DataMar 2021–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+68% above
+
Price vs 50-day avg
+86% above
◦
RSI (14)
58 · neutral
+
MACD trend
positive
◦
52-week position
27% · mid-range
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $3 › 200d $4 — 200d above 50d
−
Institutional flow
-50% holders QoQ
◦
Insider flow
No net insider activity over 90 days
−
Short interest
2.07% of float · ▲ +25.7% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — near 1-yr low, contrarian setup
Fundamentals
Strong
−
Revenue growth
−22% Y/Y
+
Gross margin
35%, expanding
+
EPS growth
+99% Y/Y
−
Free cash flow
$-5.3B
+
Balance sheet
net cash $8.1M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ4-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+68% above
Bullish
Price vs 50-day avg
+86% above
Bullish
RSI (14)
58 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
27% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Distributing
-50% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.07% of float · ▲ +25.7% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $2
Now $6 · 27%
52-wk high $18
vs 200-day avg +68%
vs 50-day avg +86%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UPC
this stock
Universe Pharmaceuticals INC
|
$4.20M | +65.9% | -22.4% | — | 2.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.2%
- Net QoQ
- -1.1K sh
- Top holder
- SABBY MANAGEMENT, LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UPC | +122.5% | +83.7% | +49.8% | +3.6% | +65.9% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +121.1% | +85.0% | +41.7% | +3.9% | +56.7% |
Key facts
CIK
1809616
CUSIP
G9442G138